Ewa Janczewska
0000-0002-5406-4603
Medical University of Silesia
148 papers found
Refreshing results…
Association of serum sVCAM-1 concentration with fibrosis stage and inflammatory activity grade in chronic hepatitis C patients.
Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-β1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C
sPECAM-1 as a marker of inflammatory activity, fribrosis stage and response to antiviral therapy in chronic hepatitis C.
Efekty reterapii interferonem pegylowanym α2a, rybawiryną po nieskutecznym leczeniu interferonem α2b (IFNα2b) i RBV w różnych grupach chorych z przewlekłym zapaleniem wątroby typu C (PWZWC).
Re-therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C previously treated with interferon alpha and ribavirin.
Chronic hepatitis C coexisting with toxic and autoimmune lesions after Hodgkin lymphoma treatment.
Treatment of hepatitis C virus (HCV) infection in HIV-infected subjects, receiving and not receiving antiretroviral treatment
Assessment of antiviral treatment efficacy in patients with chronic hepatitis C by immunohistochemical detection of NS3 HCV antigen in liver tissue.
Therapy with natural leukocyte interferon and ribavirine in "difficult to treat" patients infected with HCV.
Therapy with natural leukocyte interferon and ribavirine in "difficult to treat" patients with HCV.
Infections with hepatitis B and C viruses in haemodialysed patients.
Profilaktyka zakażeń wirusowych i bakteryjnych w marskości wątroby.
Usefulness of sVCAM-1 in the assessment of liver fibrosis and inflammatory activity in patients with chronic hepatitis C.
Immunohistochemical assessment of TGF-beta expression in the liver tissue of morbidly obese patients.
Re-treatment with pegylated and natural leukocyte interferon and ribavirin in cirrhotic patients infected with HCV - preliminary report.
Tissue expression of hepatitis C virus antigen in liver specimens of patients with chronic hepatitis C before and after successful antiviral treatment : Is eradication possible?
Analiza wyników reterapii po nieskutecznym leczeniu interferonem alfa (IFN) i rybawiryną (RBV) u chorych z marskością wątroby na tle zakażenia HCV - obserwacje wstępne.
HBV and HCV infections in hemodialyzed patients of Opole region.
Autoimmune thyroid disease in patients with chronic hepatitis B (HB) and hepatitis C (HC) before and after interferon-alpha (IFN) therapy.
Współczesne możliwości zapobiegania chorobom wywołanym przez pneumokoki.
Missing publications? Search for publications with a matching author name.